All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
January 2025: Update to seborrhoeic dermatitis guidance
News
January 2025: Update to seborrhoeic dermatitis guidance
Management of seborrhoeic dermatitis
Updates include:
- Advice on treatment for those aged from birth to 18 years
- Updates to treatment options, including:
- the addition of topical calcineurin inhibitors as amber (specialist input) options
- the removal of combination steroid and antimicrobial product recommendations
- Supporting information on treatment durations and licensed age ranges
- Advice on reassessment and referral, including links to local Clinical Referral Guidelines (CRGs).
See here for the formulary guidance.
